No Detail Found!

Basil leaf extract and eugenol against isolates of Candida sp. causing oral candidiasis in HIV/AIDS

Author(s)
Dwi Murtiastutik Department of Dermatology and Venereology, Dr. Soetomo General Academic Teaching Hospital, Surabaya, Indonesia
Emma Hidayati Sasmito Department of Dermatology and Venereology, Dr. Soetomo General Academic Teaching Hospital, Surabaya, Indonesia
Afif Nurul Hidayati Department of Dermatology and Venereology, Dr. Soetomo General Academic Teaching Hospital, Surabaya, Indonesia.;Department of Dermatology and Venereology, Universitas Airlangga Teaching Hospital, Surabaya, Indonesia
Rahmadewi Department of Dermatology and Venereology, Dr. Soetomo General Academic Teaching Hospital, Surabaya, Indonesia.
Sawitri Department of Dermatology and Venereology, Dr. Soetomo General Academic Teaching Hospital, Surabaya, Indonesia.
Budi Utomo Department of Public Health and Preventive Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
Sudjarwo Department of Pharmaceutical Science, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
Pepy Dwi Endraswari Department of Clinical Microbiology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Teaching Hospital, Surabaya, Indonesia. Department of Clinical Microbiology, Universitas Airlangga Teaching Hospital, Surabaya, Indonesia
Diah Mira Indramaya Department of Dermatology and Venereology, Dr. Soetomo General Academic Teaching Hospital, Surabaya, Indonesia
Abstract
Background Oral candidiasis is an opportunistic infection of the oral mucosa caused by Candida sp., frequently found in HIV/AIDS patients. Basil leaf extract (Ocimum sanctum Linn.), which contains eugenol, a compound believed to inhibit the growth of Candida sp. Objective To evaluate the antifungal effect of basil leaf extract (Ocimum sanctum Linn.) and eugenol compared to fluconazole against Candida sp. isolates. Methods Basil leaf extract (Ocimum sanctum Linn.) with doses equivalent to eugenol 800 µg/mL and 400 µg/mL, eugenol doses at 800 µg/mL and 400 µg/mL, which was then compared with fluconazole 25 µg/mL against 40 Candida sp. isolated stored from the oral cavity of HIV/AIDS patients. Results The average inhibition zone of fluconazole was 21.81 mm, the mean inhibition zone of eugenol with doses of 800 µg/mL and 400 µg/mL were 17.07 mm and 15.89 mm, and the mean inhibition zone of basil leaf extract (Ocimum sanctum Linn.) with doses equivalent to eugenol 800 µg/mL and 400 µg/mL were 14.87 mm and 14.01 mm (p = 0.001 and p < 0.05). Conclusion Fluconazole had a significantly higher inhibition zone against Candida albicans and Candida non-albicans isolates than basil leaf extract (Ocimum sanctum Linn.) and eugenol.
Publication Details
Page(s) 669-675
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 32, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
aids, oral candidiasis, Eugenol, Basil leaf extract (Ocimum sanctum Linn, Fluconazole, antifungal susceptibility testing
0

Citations

0

Downloads

44

Views